Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
DOJ
Sun Pharma Subsidiary Agrees to Pay $20.75 Million to Resolve False Claims…
At the end of August 2020, Massachusetts-based DUSA Pharmaceuticals (DUSA) – a subsidiary of Sun Pharmaceutical Industries, Inc.…
Government Intervenes against Device Manufacturer Spine Frontier and its…
Earlier this year, the U.S. Department of Justice (DOJ) announced it had intervened in a False Claims Act case against a medical…
HHS and DOJ Release Annual Fraud and Abuse Report
This summer, the United States Department of Health and Human Services (HHS) and Department of Justice (DOJ) released the Health…
Individual NextHealth Marketer Indicted in $60 Million Kickback Scheme
On August 18, 2020, healthcare marketer Vinson Woodlee was indicted on one count of conspiracy to pay and receive healthcare…
Teva Hit with False Claims Act Suit Over Copaxone
Recently, the United States Attorney’s Office for the District of Massachusetts filed a complaint under the False Claims Act (FCA)…
DOJ Settles Kickback Suit with Cordant Health Solutions
In late July 2020, the United States Department of Justice (DOJ) announced a civil suit settlement with Sterling Healthcare Opco,…
DOJ Will Allow Monoclonal Antibody Manufacturers to Share Information in…
The United States Department of Justice recently announced that it does not plan to challenge proposed efforts by a handful of…
Taro Enters into Deferred Prosecution Agreement Over Generic Drug Scheme
On July 23, 2020, the United States Department of Justice (DOJ) announced that Taro Pharmaceuticals U.S.A., Inc. (Taro) was…
Reuters Reports PerkinElmer Under Investigation for Medicare Fraud
According to a May 18, 2020 Reuters article, the medical diagnostic firm PerkinElmer, Inc. is involved in a federal investigation…
Novartis Settlements and Corporate Integrity Agreement 2020 Version 3.0
Last week, the United States Department of Justice (DOJ) announced a $642 million settlement with Novartis over improper payments…